Tramadol Hydrochloride Tablet, Extended Release
Product Images NDC 68071-1671

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Tramadol Hydrochloride (NDC 68071-1671). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Nucare Pharmaceuticals,inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Image-1 (33a5de83 A974 48a5 8ba6 4c1b97515615 01)

Chemical structure diagram of tramadol hydrochloride, showing its molecular configuration with specific hydroxyl, methyl, and aromatic groups, as indicated in the product data for the drug tramadol hydrochloride.*

FDA Label Image

Image-2 (33a5de83 A974 48a5 8ba6 4c1b97515615 02)

A line graph comparing Tramadol concentration (ng/mL) over 24 hours for two different oral tablet formulations: Tramadol Hydrochloride Extended-Release Tablets 200 mg once daily (q.d.) and Tramadol Hydrochloride Tablets 50 mg every 6 hours (q6h). The x-axis represents time in hours, and the y-axis shows tramadol concentration in ng/mL.*

FDA Label Image

Image-3 (33a5de83 A974 48a5 8ba6 4c1b97515615 03)

A line graph comparing M1 metabolite concentration (ng/mL) over 24 hours between Tramadol Hydrochloride Extended-Release Tablets 200 mg once daily and Tramadol Hydrochloride Tablets 50 mg every 6 hours. The x-axis represents time in hours, and the y-axis shows M1 concentration with data points for each formulation.*

FDA Label Image

Image-4 (33a5de83 A974 48a5 8ba6 4c1b97515615 04)

A line chart titled 'Tramadol Hydrochloride Extended-Release Tablets Study 023 WOMAC Pain Responder Analysis' showing percent of patients achieving various levels of response threshold (percent improvement from baseline). The graph compares Tramadol Hydrochloride extended-release tablets at doses of 100 mg, 200 mg, 300 mg, and 400 mg against placebo, with percent achieving response generally decreasing as response threshold increases.*

FDA Label Image

Image-5 (33a5de83 A974 48a5 8ba6 4c1b97515615 05)

A line graph titled 'Tramadol Hydrochloride Extended-Release Tablets Study 015 Arthritis Pain Intensity VAS Responder Analysis' showing the percent of patients achieving various levels of response threshold (percent improvement from baseline). Two lines compare Tramadol Hydrochloride Extended-Release Tablets and Placebo across response thresholds from 0 to 100 percent, with Tramadol showing consistently higher patient response rates than placebo.*

FDA Label Image

Pdp (68071 1671 3)

Label for TRAMADOL HYDROCHLORIDE 100 mg extended release oral tablets from NuCare Pharmaceuticals, Inc. The label indicates a package size of 30 tablets and lists the manufacturer as Lupin Limited, India. It includes NDC 68071-1671-3 and instructions to take the medication every specified number of hours. The label features a schedule IV controlled substance symbol and warnings about keeping out of reach of children and storing at controlled temperature.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.